Table 1 Demographic and clinical characteristics of the included patients.
Characteristic | All patients (n = 254) |
|---|---|
Age, year | 65.6 (54.3–74.2) |
Male gender | 159 (63%) |
Body weight, kg | 82.0 (72.0–95.0) |
BSA, m2 | 1.97 (1.82–2.10) |
Gentamicin dose, mg/kg | 3.2 (2.2-4.0) |
Serum gentamicin concentration, mg/L | 3.1 (2.0-4.4) |
eGFRCreatinine, ml/min/1.73m2 BSA | 55 (33–83) |
eGFRCystatinC, ml/min/1.73m2 BSA | 45 (28–71) |
eGFRGentamicin, ml/min/1.73m2 BSA | 43 (27–62) |
Renal placement therapy during ICU care | 28 (11%) |
30-day mortality | 49 (19%) |
Days from gentamicin sampling to death | 1475 (63-3129) |